On April 3, 2023, the US Food and Drug Administration (FDA) published its draft guidance, Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial ...
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including ...
On January 7, 2024, the U.S. Food and Drug Administration (FDA) published the draft guidance “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission ...
Please provide your email address to receive an email when new articles are posted on . FDA granted fast track designation to Palisade Bio’s broad-spectrum serine protease inhibitor, LB1148, for ...
"The approval of the TGFR by the FDA demonstrates our proprietary system can provide an effective option for assessing kidney function," said Steve Hanley, CEO of MediBeacon. "According to the ...
On August 8, 2025, the FDA granted accelerated approval to zongertinib for adult patients with unresectable or metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results